Literature DB >> 12609244

The course of inattentive and hyperactive-impulsive symptoms in children with new onset seizures.

Jane Williams1, Bernadette Lange, Tonya Phillips, Gregory B. Sharp, Emily DelosReyes, Stephen Bates, May L. Griebel, Pippa Simpson.   

Abstract

The purpose of the present study was to determine the prevalence of inattentive and hyperactive-impulsive symptoms in children with newly diagnosed epilepsy, explore the course of these symptoms over time, and examine factors associated with change in these symptoms. Parents of children (n=42) were administered the Attention Deficit Disorder Evaluation Scale-Home Version (ADDES-HV) at the time of diagnosis. The ADDES-HV was readministered after the child's seizures were controlled. Prior to initiation of anticonvulsant therapy, 31% of the children were rated as having clinically significant problems with inattention and 31% with hyperactivity-impulsivity. At follow-up, 27% had elevated symptoms of inattention and 24% had hyperactivity-impulsivity. Analysis of this change indicated that children with a normal MRI were more likely to have decreased hyperactive-impulsive behaviors following control of their seizures. Results suggest the need for assessment and monitoring of attention in children with epilepsy.

Entities:  

Year:  2002        PMID: 12609244     DOI: 10.1016/s1525-5050(02)00532-2

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  2 in total

1.  Impaired attention and network connectivity in childhood absence epilepsy.

Authors:  Brendan D Killory; Xiaoxiao Bai; Michiro Negishi; Clemente Vega; Marisa N Spann; Matthew Vestal; Jennifer Guo; Rachel Berman; Nathan Danielson; Jerry Trejo; David Shisler; Edward J Novotny; R Todd Constable; Hal Blumenfeld
Journal:  Neuroimage       Date:  2011-03-21       Impact factor: 6.556

2.  Differentiation of attention-related problems in childhood absence epilepsy.

Authors:  Clemente Vega; Matthew Vestal; Matthew DeSalvo; Rachel Berman; Mihae Chung; Hal Blumenfeld; Marisa N Spann
Journal:  Epilepsy Behav       Date:  2010-08-02       Impact factor: 2.937

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.